Durvalumab vs Lorazepam

Durvalumab vs Lorazepam: Overview

This comparison examines the pharmacological differences between Durvalumab and Lorazepam.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Lorazepam: Intermediate-acting benzodiazepine enhancing GABA-A receptor chloride conductance.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Lorazepam — 10-20 hours.

Chemical Properties

Molecular Formula: Lorazepam — C15H10Cl2N2O2.

Molecular Weight: Lorazepam — 321.1580 g/mol.

Type: Durvalumab — Antibody; Lorazepam — Small molecule.